Use Of Karpaskulatthikadi Pottali Sweda In Amavata

An Open Randomized Controlled Clinical Trial Of Karpaskulatthikadi Pottali Sweda In Amavata With Special Reference To Rheumatoid Arthritis. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085325

Enrollment

Registered

2025-04-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having the signs and symptoms of Amavata; Sandhishool, Sandhishoth, Sparshasahtva, Sandhi Stabhata, Jwara 2. Patient will be selected irrespective of gender, occupation, and habitat, religion. 3. Patient fit for Pottali Sweda. 4. Chronicity less than 5 yrs. 5. First and second stage of Rheumatoid Arthritis

Exclusion criteria

Exclusion criteria: 1. Third and Fourth stage of Rheumatoid Arthritis 2. Juvenile Rheumatoid Arthritis 3. Skin diseases, Infectious disease like Osteomyelitis, tuberculosis, Malignancy. 4. Any surgical condition such as Patient with trauma or Accident, fracture, any open wound. 5. Patients with Sandhi Vakrata. 6. Pregnant women, lactating mothers 7. Steroid dependent. 8. Patients is on NSAID.

Design outcomes

Secondary

Measure	Time frame
Valuka Pottali Sweda Is Effective In The Management Of AmavataTimepoint: 7 Days	—

Primary

Measure	Time frame
Karpaskulstthikadi Pottali Sweda Is Effective In The Management Of AmavataTimepoint: 7 Days	—

Countries

India

Contacts

Public ContactDr Shankar Mane

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta

shnkrmane@gmail.com9922454406

Outcome results